The efficacy of ultraviolet A1 phototherapy in psoriasis: A pilot study

Not Applicable

Recruiting

• Conditions: Patients with chronic plaque type psoriasis; Psoriasis, Phototherapy, Ultraviolet A1

• Registration Number: TCTR20170602001
• Lead Sponsor: Department of dermatology, Siriraj Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-02
• Study Completion: 2017-12-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1. Patients affected by moderate-to-severe psoriatic plaques.
2. Stopping topical therapy other than emollients within the
previous 2 weeks.
3. Stopping systemic immunomodulating or immunosuppressive
therapy within the last 1 month.

Exclusion Criteria

1. Pregnancy
2. Patients with history of photodermatoses or skin cancer
3. Patients with history of photosensitivity

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Efficacy and safety of ultraviolet A1 phototherapy in psoriasis. 4 months Photographs, PASI Score, BSA, DLQI, Histology

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A